early-lineage stem cells used in research-stage protocols.
Fetal stem cells carry broad differentiation potential and low immunogenicity. They form the historical core of several European regenerative programmes and remain a defined research area.
The therapeutic value of Fetal Stem Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.
Educational information. Fetal Stem Cells protocols for several conditions remain investigational; outcomes vary by patient.
Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.
Evaluación médica gratuita